Tevimbra is already approved in the US for the treatment of unresectable or metastatic oesophageal squamous cell carcinoma ...

Dostarlimab is under clinical development by GSK and currently in Phase II for Adenocarcinoma Of The Gastroesophageal Junction.

Evalstotug is under clinical development by BioAtla and currently in Phase II for Gastric Cancer. According to GlobalData, Phase II drugs for Gastric Cancer have a 28% phase transition success rate ...

San Mateo, California Monday, December 30, 2024, 18:00 Hrs [IST] ...

More research is needed to refine treatment strategies and identify predictive biomarkers for patient selection, according to researchers.

INR:0934. jai vs up kabaddi US$570 million! Leo obtains exclusive global license for new dermatitis and asthma drugs from companies on both sides of the Taiwan ...

INR:2435. charminar satta chart 2022 Review of clinical developments of China's Class 1 new drugs in February 2020 Tumor Therapeutic Fields + Chemother ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the ...

By inhibiting the DNA polymerases, BKC enhances the endogenous RS in cancer cells, leading to increased DNA damage. IBC specifically inhibits CHK2 to prevent DNA repair. The combined use of BKC and ...

INR:3656. cricket sa vs ind BeiGene's tislelizumab combined with chemotherapy has strong efficacy in treating gastric cancer/esophageal cancer How long can Cell ...